Company / R&D per Share
Silo Pharma, Inc. R&D per Share History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$0.53
FY2025
5-year range
$0.00 / $0.53
FY2021-FY2025
Trend
+81.6%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $0.41 to $0.53 over the past 2 years.
Based on SEC 10-K filings.
0.53 in FY2025 with a 5-year CAGR of +243.0%.
Improved from $0.41 to $0.53 over the past 2 years.
R&D per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- +243.0%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, r&d per share increased 81.6% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 0.67 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.53 | +81.6% |
| FY2024 | $0.29 | -28.6% |
| FY2023 | $0.41 | +36520.6% |
| FY2020 | $0.00 | - |
| FY2019 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026